Commentary: What is the optimal duration of antibiotic therapy?

British Medical Journal

Volumn 332, Issue 7554, 2006, Pages 1358-

  Paul, John ^a  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; PENICILLIN G; PLACEBO; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIAL ENDOCARDITIS; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; HEALTH CARE COST; HUMAN; META ANALYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOTE; PHARYNGITIS; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; SYSTEMATIC REVIEW; TREATMENT DURATION; BACTERIAL INFECTION; DRUG ADMINISTRATION; RECURRENT DISEASE; TIME;

ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; DRUG ADMINISTRATION SCHEDULE; HUMANS; RECURRENCE; TIME FACTORS;

EID: 33745003880     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (4)

1. El Moussaoui R, de Borgie CAJM, van den Broek P, Hustinx WN, Bresser P, van den Berk GEL, et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ 2006;332:1355-8.
2. British Thoracic Society Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults. Thorax 2001;56(suppl IV):1-64.
3. Casey JR, Pichichero ME. Meta-analysis of short course antibiotic treatment for Group A streptococcal tonsillopharyngitis. Paediatr Infect Dis J 2005;24:909-17.
4. Fowler VG Jr, Sanders LL, Sexton DJ, Kong L, Man KA, Gopal AK, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998;27:478-86.